Press Releases

Nokia (NYSE: NOK) Forms Base
Once the darling of the cell phone set, Nokia (NYSE: NOK) has lost a lot of respect to Apple (Nasdaq: AAPL) and Research in Motion (Nasdaq: RIMM).



Chart Courtesy of StockCharts.com




Nokia's problem is that it's lost market share to Apple, RIMM, and others. Nokia's advantage is that it still has about a 34% share of the cell phone market. That means that based on volume, it's still the leader.

What it doesn't have is a killer phone like the Blackberry or the Iphone. Yet, if you look at the stock, it's starting to form a base, and it's showing a bit more strength.

Apple and RIMM shares are both starting to struggle. Nokia is selling at less than ten times earnings, which makes it cheap. Apple sells at 33 times earnings and RIMM at 17 times.

So that means that Nokia is the cheapest of the three, while having the leading market share. The question, though, is whether Nokia can keep its market share from eroding further.

Still, it current trends remain in place, Nokia's market share is likely to continue to drop. Unless, of course, anyone who's ever going to buy an I-phone or a Blackberry has already done so, which is hard to believe.

What's the point? The company that comes up with the next generation gadget that really rules the roost, is likely to solidify its place in the cell phone wars. It could be anyone of these three. For now, the charts say that value players may be starting to build positions in Nokia.

The stock is worth watching very carefully. We give it 3-stars right now.

Make money if any market rises or falls, with a copy of "Market Timing For Dummies."

“Futures And Options For Dummies,” Dr. Duarte’s latest book is now available. The markets are responding to news and geopolitical developments like never before. In this environment, individual investors need to expand their investment horizons. "Futures And Options For Dummies " (John Wiley & Sons) has an excellent section on oil futures as well as the currency markets, while covering and expanding on the successful strategies in Doctor Duarte's other books. Order your copy today.

Doctor Joe Duarte's Market I.Q., offers subscribers a unique blend of intelligence, market commentary and trading strategy. Duarte's daily articles, and news summaries offer recommendations and analysis for ETFs, and individual stocks in the technology, health and biotechnology, and energy sectors. Doctor Duarte is a writer, and an emerging futurist, with a diverse background, and a growing audience. His combined expertise in health care, energy, and the effects of politics and global intelligence on the financial markets offer a unique blend of insight and information to thousands of active investors and political and intelligence aficionados around the world on a daily basis.

He is the author of four books: "Futures And Options For Dummies," "Successful Energy Sector Investing," "Successful Biotech Investing" and co-author of "After-Hours Trading Made Easy."

In early 2001 Dr. Duarte in "Successful Energy Sector Investing," correctly predicted that Venezuela's political problems could lead to an energy crisis in the United States.

In 2003, also Dr. Duarte was among the first to widely publicize the long-term friendship between French President Jacques Chirac and Saddam Hussein.

He has also appeared as a weekly guest on Market Mavens Radio, has logged appearances on KNX radio in Los Angeles, Financial Sense.com radio, and Wall Street Radio.

One of CNBC's original Market Mavens, Dr. Duarte has been writing about the financial markets since 1990.

His articles and commentary have been featured on CBS Marketwatch, Barron's, Smart Money, Medical Economics, and in Technical Analysis of Stocks and Commodities magazines.

In 2003, Doctor Duarte received second place, in the professional section, of the Medical Economics Investment Challenge with a 12-month return of 42%.




Joe-Duarte.com is independently operated and solely funded by subscriber fees. This web site and the content provided is meant for educational purposes only and is not a solicitation to buy or sell any securities or investments. All sources of information are believed to be accurate, or as otherwise stated. Dr. Duarte and the publishers, partners, and staff of Joe-Duarte.com have no financial interest in any of the sources used. For independent investment advice consult your financial advisor. The analysis and conclusions reached on Joe-Duarte.com are the sole property of Dr. Joe Duarte.